Greenlane Stock Skyrockets On Plans To Distribute High-Sensitivity Test Strips To Tackle Opiate Crisis
Seller of cannabis accessories and vaporization products Greenlane Holdings, Inc. (NASDAQ: GNLN) announced on Monday plans to distribute Safety Strips, Inc.'s fentanyl, xylazine and drink spike detection test strips across the U.S."We are excited and proud to provide Safety Strips affordable and highly accurate tests with trace level fentanyl and xylazine detection capabilities to our customers throughout the U.S.," Barbara Sher, CEO of Greenlane, commented on the company's decision to enter into a non-binding letter of intent to be the exclusive distributor of Safety Strips.She added, "Safety Strips products are an innovative and complementary addition to our extensive product portfolio, and we plan to leverage our strong distribution, operations, marketing and sales teams to support the brand. We look forward to growing the business together."
